Skip to content

Enterprise value at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Merck & Co. logo
Merck & Co.MRK
$341.11B+34.2%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$8.16B+187%
UroGen Pharma logo
UroGen PharmaURGN
$962.43M+80.9%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$2.8B+110%
CG Oncology logo
CG OncologyCGON
$5.69B+212%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Calculated from Aura Biosciences, Inc.’s reported figures.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s enterprise value?
Aura Biosciences, Inc. (AURA) reported enterprise value of $361.36M in Q1 2026.
How has Aura Biosciences, Inc.'s enterprise value changed year-over-year?
Aura Biosciences, Inc.'s enterprise value increased by 31.6% year-over-year, from $274.54M to $361.36M.
What is the long-term trend for Aura Biosciences, Inc.'s enterprise value?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s enterprise value has grown at a -3.3% compound annual growth rate (CAGR), from $347.91M to $303.95M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.